nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of Efficacy and Tolerability of Bruton Tyrosine Kinase Inhibitor Ibrutinib in Various B-cell Malignancies in the General Community: A Single-center Experience
|
Ali, Naveed |
|
2017 |
17 |
S |
p. S53-S61 9 p. |
artikel |
2 |
Analysis of Survival of Patients with Chronic Myeloid Leukemia Treated with Imatinib in the Last 15 Years in Lebanon
|
Massoud, Marcel |
|
2017 |
17 |
S |
p. S111-S115 5 p. |
artikel |
3 |
Autologous Stem Cell Transplant: Still the Standard for Fit Patients With Mantle Cell Lymphoma
|
Staton, Ashley D. |
|
2017 |
17 |
S |
p. S96-S99 4 p. |
artikel |
4 |
Developmental Therapeutics in Myeloproliferative Neoplasms
|
Bose, Prithviraj |
|
2017 |
17 |
S |
p. S43-S52 10 p. |
artikel |
5 |
Diagnostic Challenges of Hemophagocytic Lymphohistiocytosis
|
Otrock, Zaher K. |
|
2017 |
17 |
S |
p. S105-S110 6 p. |
artikel |
6 |
Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms
|
Patel, Umang |
|
2017 |
17 |
S |
p. S62-S74 13 p. |
artikel |
7 |
Editorial Board
|
|
|
2017 |
17 |
S |
p. A1- 1 p. |
artikel |
8 |
First-line Therapeutic Strategies for Myelodysplastic Syndromes
|
Santini, Valeria |
|
2017 |
17 |
S |
p. S31-S36 6 p. |
artikel |
9 |
High-risk Multiple Myeloma: Definition and Management
|
Joseph, Nisha S. |
|
2017 |
17 |
S |
p. S80-S87 8 p. |
artikel |
10 |
Is Disease-Specific Immunotherapy a Potential Reality for MDS?
|
Sallman, David A. |
|
2017 |
17 |
S |
p. S26-S30 5 p. |
artikel |
11 |
Management of Patients With Histologic Transformation
|
Reddy, Nishitha M. |
|
2017 |
17 |
S |
p. S100-S104 5 p. |
artikel |
12 |
Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia
|
Bassan, Renato |
|
2017 |
17 |
S |
p. S2-S9 8 p. |
artikel |
13 |
Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument “Pro”
|
Bachanova, Veronika |
|
2017 |
17 |
S |
p. S10-S15 6 p. |
artikel |
14 |
Proceedings of the Fourth Annual Meeting of the Society of Hematologic Oncology
|
|
|
2017 |
17 |
S |
p. S1- 1 p. |
artikel |
15 |
Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune Checkpoints
|
Hidalgo-López, Juliana E. |
|
2017 |
17 |
S |
p. S16-S25 10 p. |
artikel |
16 |
Real-life Experience for Integration of PET-CT in the Treatment of Hodgkin Lymphoma in Lebanon
|
Sakr, Riwa |
|
2017 |
17 |
S |
p. S92-S95 4 p. |
artikel |
17 |
Survival Pattern of Hodgkin Lymphoma Patients in the Last 25 Years in Lebanon
|
Massoud, Marcel |
|
2017 |
17 |
S |
p. S88-S91 4 p. |
artikel |
18 |
Table of Contents
|
|
|
2017 |
17 |
S |
p. A2-A4 nvt p. |
artikel |
19 |
The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms
|
Ragon, Brittany Knick |
|
2017 |
17 |
S |
p. S37-S42 6 p. |
artikel |
20 |
Treatment Choices: A Quality of Life Comparison in Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
|
Tinsley, Sara M. |
|
2017 |
17 |
S |
p. S75-S79 5 p. |
artikel |